Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine

BACKGROUND: In October 2009, 7-valent pneumococcal conjugate vaccine (PCV7: Prevenar(TM) Pfizer) was replaced in the Northern Territory childhood vaccination schedule by 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10; Synflorix™ GlaxoSmithKline Vaccines). This a...

Descripción completa

Detalles Bibliográficos
Autores principales: Leach, Amanda Jane, Wigger, Christine, Hare, Kim, Hampton, Vanya, Beissbarth, Jemima, Andrews, Ross, Chatfield, Mark, Smith-Vaughan, Heidi, Morris, Peter Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615539/
https://www.ncbi.nlm.nih.gov/pubmed/26482232
http://dx.doi.org/10.1186/s12887-015-0483-8

Ejemplares similares

Ejemplares similares